A peer‐based intervention to educate liver transplant candidates about living donor liver transplantation

Samantha DeLair, Thomas Hugh Feeley, Hyunjung Kim, Juan del Rio Martin, Leona Kim‐Schluger, Dianne LaPointe Rudow, Mark Orloff, Patricia A. Sheiner, Lewis Teperman – 23 December 2009 – The number of liver donors has not measurably increased since 2004 and has begun to decrease. Although many waitlisted patients may be suitable candidates to receive a living donor graft, they are often reticent to discuss living donation with close friends and family, partly because of a lack of knowledge about donor health and quality of life outcomes after donation.

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study

Aurelie Plessier, Sarwa Darwish‐Murad, Manuel Hernandez‐Guerra, Yann Consigny, Federica Fabris, Jonel Trebicka, Jorg Heller, Isabelle Morard, Luc Lasser, Philippe Langlet, Marie‐Hélène Denninger, Dominique Vidaud, Bertrand Condat, Antoine Hadengue, Massimo Primignani, Juan‐Carlos Garcia‐Pagan, Harry L. A. Janssen, Dominique Valla, European Network for Vascular Disorders of the Liver (EN‐Vie) – 23 December 2009 – Current recommendations for early anticoagulation in acute portal vein thrombosis unrelated to cirrhosis or malignancy are based on limited evidence.

Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype‐specific immunodominant CD8+ T‐cell epitope

Christoph Neumann‐Haefelin, Jörg Timm, Julia Schmidt, Nadine Kersting, Karen Fitzmaurice, Cesar Oniangue‐Ndza, Michael N. Kemper, Isla Humphreys, Susan McKiernan, Dermot Kelleher, Volker Lohmann, Paul Bowness, Daniela Huzly, Hugo R. Rosen, Arthur Y. Kim, Georg M. Lauer, Todd M. Allen, Eleanor Barnes, Michael Roggendorf, Hubert E. Blum, Robert Thimme – 23 December 2009 – Human leukocyte antigen B27 (HLA‐B27) is associated with protection in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection.

Use of thromboelastography PlateletMapping™ to monitor antithrombotic therapy in a patient with Budd‐Chiari syndrome

Katherine James, Elisa Bertoja, James O'Beirne, Susan Mallett – 23 December 2009 – Budd‐Chiari syndrome (BCS) is the end result of a number of disease states resulting in hepatic venous outflow obstruction. We report a Janus kinase 2–homozygous patient with BCS who thrombosed a transjugular intrahepatic portosystemic shunt (TIPS) despite treatment with warfarin (international normalized ratio = 3.0), aspirin, and clopidogrel.

Glycoprotein 130–dependent pathways in host hepatocytes are important for liver repopulation in mice

Darjus F. Tschaharganeh, Michaela Kaldenbach, Stephanie Erschfeld, Jens J. W. Tischendorf, Christian Trautwein, Konrad L. Streetz – 23 December 2009 – Hepatocyte transplantation (HT) is still restricted by the limited amount of transplantable cells. Therefore, a better understanding of the mechanisms involved in cellular engraftment, proliferation, and in vivo selection is important. Here we aimed to evaluate the role of the interleukin 6 (IL‐6)/glycoprotein 130 (gp130) system for liver repopulation.

Subscribe to